Clinical Trial

Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)

Study acronym: VAMP-Aging
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.
Trial Details
NCT Number NCT07563725
Lead Sponsor National Institute of Cardiology, Laranjeiras, Brazil
Conditions Aging Problems
Enrollment 62 participants
Start Date 2026-06
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-04